Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Labels:

Popular posts in the last week

The EU Commission Plans for Rearmament and a Clean Industrial Deal

Internationalism No. 71, January 2025 Page 2 From the series European news Following the European elections which took place on June 6th - 9th, the leaders of the Member States met on June 27th at the European Council. Ursula von der Leyen was nominated as president of the next European Commission, after she was chosen as the European People’s Party’s (EPP) Spitzenkandidat (“leading candidate”). The agreement also included the election of former Portuguese Prime Minister Antonio Costa as president of the European Council, and the appointment of former Estonian Prime Minister Kaja Kallas as High Representative of the Union for Foreign Affairs and Security Policy. Subsequently, on July 18th, Parliament elected von der Leyen as president of the Commission by an absolute majority, with 401 votes out of 719 MEPs. On September 17th, von der Leyen presented her team of commissioners to the European Parliament and, two days later, the Council adopted this list of...
Read more

Libertarian Communism: A Different Kind of Communism

Chapter Three LIBERTARIAN COMMUNISM: A DIFFERENT KIND OF COMMUNISM   An examination of the debate within the groups that were to create GAAP (Anarchist Groups of Proletarian Action) gives a vivid picture of the problems that between 1948 and 1951 had to be slowly and painfully faced. Three major confrontations, progressively more serious, took place between Cervetto and Masini in the autumn of 1949 and again in the spring and autumn of 1950. As preparations were being made for the National Conference at Pontedecimo – from which GAAP would be born – debate on the nature of the organisation and on theories of the State and imperialism began to define the characteristics of the new political group, but also revealed the differences. The first step had been to look for ‘a different kind’ of communism in anarchism. Along this road Cervetto , with an ever-surer grasp, would raise the issue that had been first posed by Marx and Lenin : our militant...
Read more

Lotta Comunista: The Origins 1943-1952

Guido La Barbera Contents 9. Preface to the English Edition 13. Preface 19. Useful dates 21. Chapter One «ONE OUGHT TO KNOW WITH WHOM ONE IS DEALING» 25. The balance-of-power theory 27. Theory and the ‘strategy-party’ 29. Chapter Two THE FOUNDRY AND THE PARTISAN STRUGGLE 31. The Savona group 39. Passion disciplined by reason 40. Never again a tool in the hands of others 41. The Genoa group 46. The Sestri Ponente group 48. The groups in Rome and Tuscany 52. The strength of GAAP: ‘only a handful’ 55. Chapter Three LIBERTARIAN COMMUNISM: A DIFFERENT KIND OF COMMUNISM 58. Reckoning with Bordiga...
Read more

Socialism and Nationalism in the History of France

The collapse of French socialism at the outbreak of the First World War is considered by many historians to be the most significant case of its kind. We must go back in time to find its origins. The dramatic repression of the Paris Commune in 1871 was followed by a decade of shootings and the deportation of tens of thousands of revolutionary militants. Reactionary monarchical legitimism attributed the decline of France to the Revolution of 1789, but by then the nouvelles couches sociales , the new classes produced by capitalism, as Leon Gambetta defined them, demanded a politics free from economic, social and clerical ties. The Radical Party, a turning point of French politics, was its expression. The same taditional Catholic Judeophobia dating back to the Middle Ages — according to Michel Dreyfus’, research director at the CNRS in Paris, Anti-Semitism on the Left in France [Paris, 2009] — gradually transformed into the image of the Jews associated with money and modernity who des...
Read more

The Myth of Cooperation

From the series Vaccines and world contention There are by now ten authorised vaccines already in use against SARSCoV-2, and there are 77 countries in which vaccinations are taking place. By mid-February, 173 million doses had been administered and the campaign is proceeding at an average rate of six million a day, calculated on the basis of last week’s figures. At this pace, it would take 5 years to vaccinate 75% of the world population with two doses [ Bloomberg , February 15 th ]. More than half of the injections have been carried out in the United States, the UK, and the European Union which, together, account for 11% of the world population. In at least one third of the 77 surveyed countries, less than 1% of the population have received their first dose of the vaccine, and, in the rest of the world, vaccines have not yet arrived. Imperialist globalisation Individual states are pursuing autonomous solutions to a global problem. Epidemiologists believe that, while a vast propo...
Read more

Show Warfare?

Internationalism No. 86, April 2026 Page 16 After show politics and show diplomacy , have we sunk to the obscenity of show warfare ? On the surface, this is true. The Pentagon’s video game-style communications, where airstrikes, missile launches, and deadly explosions are set to music for social media clips, certainly suggest so. It matters little that a hundred schoolgirls were also blown to bits as artificial intelligence took centre stage on the battlefield. In reality, war propaganda has always showcased destruction and mocked the enemy; today in Washington, in the era of the high-tech groups of television and social media democracy , the only thing that has changed is the style and the means used to inflame fanaticisms and stuff people’s brains. In Tehran, dominated by a parasitic bourgeoisie that feeds on oil revenues and is intertwined with the militias and hierarchies of t...
Read more

Democratic Defeat in the Urban Vote

Internationalism No. 71, January 2025 Page 2 From the series Elections in the USA A careful analysis of the 2022 mid-term elections revealed the symptoms of a Democratic Party malaise which subsequently fully manifested itself in the latest presidential election, with the heavy loss of support in its traditional strongholds of the metropolitan areas of New York City and Chicago, and the State of California. A defeat foretold Republican votes rose from 51 million in the previous 2018 midterms to 54 million in 2022, a gain of 3 million. The Democrat vote fell from 61 to 51 million, a loss of 10 million. The Republicans gained only three votes for every ten lost by the Democrats, while the other seven became abstentions. In 2022, we analysed the elections in New York City by borough, the governmental districts whose names are well known through movies and TV series. In The Bronx, where the average yearly household income is $35,000, the Democrats lost 52,0...
Read more

The National Gamble of Poland

Internationalism No. 33, November 2021 Page 3 From the series European News In a lawsuit brought by Prime Minister Mateusz Morawiecki, the Constitutional Tribunal, which is composed of judges chosen by the government, ruled that fundamental parts of the EU Treaty are incompatible with the Constitution of the Republic of Poland. This ruling thus denies the primacy of European law over national law, undermining both the political assumption of continental integration and the supranational character of the EU . Vectors of Polish history We can shed light on this event if we consider the four field vectors that cross Poland: its traditional ethnic-religious nationalism, its marked Atlantic tropism, the objective attraction exerted by the European force field, and the looming threat of Russia. The general picture is global collisions: China’s irruption and the crisis in the world order have put pressure on Warsaw to define its st...
Read more

The Spider Web of OpenAI Agreements

Internationalism No. 83, January 2026 Page 14 From the series The telecommunications battle There are two interwoven and contrasting trends in the American economy. On the one hand, we are witnessing steady growth in the value of securities linked to the furious race towards artificial intelligence (AI), which could lead to a financial bubble; on the other, an increase in GDP, precisely due to the huge investments in this field, is taking place. In the first week of November, a downward correction saw many technological securities devalue by $1.2 trillion on the stock exchange. Jamie Dimon, CEO of JPMorgan, the biggest American bank, predicts that there is a one-in-three probability of a collapse, albeit not imminently. As I see it — he states — artificial intelligence is real and, all in all, it will pay off [...] just as happened in the past in the case of automobiles and television sets . Products which, however, have also seen many...
Read more

The future of work in Europe

Every moment of transition presents its own complexities: for our class this means that further divisions are sown within it. Such is the present moment — one when different dynamics stack up and intertwine. Past, present and future On the one hand, there is the troubled exit from the pandemic crisis, still under the threat posed by the emergence of new Covid-19 variants. The pause on redundancies has come to an end in Italy. This, albeit partially, would have spared about 520,000 jobs in Italy up until now, according to Centro Einaudi’s estimates [ 25 th Annual Report on Global Economy and Italy , June 2021]. Company closures and staff reductions (in a mixture of arrogance and callousness) have marked the summer months, only to announce a difficult autumn, when the redundancy ban will be lifted also for small businesses and services. However, it is clear how uncertain the workers’ condition remains, regardless of any collective agreement signed, and how necessary it is always to ...
Read more